D-1340-2019 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-1340-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Jun 3, 2019 and is designated Class II. Reason for recall: Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly. The recall status is terminated (terminated May 2, 2022). Affected quantity: 31,656 boxes.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
Jun 3, 2019
Termination Date
May 2, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,656 boxes

Product description

Estradiol Vaginal Inserts USP 10 mcg, packaged in box of 8 Vaginal Inserts (with disposable applicators), Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403 513 India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430 USA, NDC 68462-711-71

Reason for recall

Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly.

Distribution pattern

U.S.A. Nationwide

Code information

Lot#: 20180516, Exp 4/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1340-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1340-2019. Report a data issue: hello@regdatalab.com.